Shefer S, Nguyen L B, Salen G, Ness G C, Tint G S, Batta A K, Hauser S, Rani I
Department of Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark 07103.
J Biol Chem. 1991 Feb 15;266(5):2693-6.
We measured hepatic cholesterol 7 alpha-hydroxylase activity, mass, and catalytic efficiency (activity/unit mass) in bile fistula rats infused intraduodenally with taurocholate and its 7 beta-hydroxy epimer, tauroursocholate, with or without mevalonolactone to supply newly synthesized cholesterol. Enzyme activity was measured by an isotope incorporation assay and enzyme mass by densitometric scanning of immunoblots using rabbit anti-rat liver cholesterol 7 alpha-hydroxylase antisera. Cholesterol 7 alpha-hydroxylase activity increased 6-fold, enzyme mass 34%, and catalytic efficiency 5-fold after interruption of the enterohepatic circulation for 48 h. When taurocholate was infused to the bile acid-depleted animals at a rate equivalent to the hepatic bile acid flux (27 mumol/100-g rat/h), cholesterol 7 alpha-hydroxylase activity and enzyme mass declined 60 and 61%, respectively. Tauroursocholate did not significantly decrease cholesterol 7 alpha-hydroxylase activity, mass and catalytic efficiency. The administration of mevalonolactone, which is converted to cholesterol, modestly increased cholesterol 7 alpha-hydroxylase activity and enzyme mass in the bile acid-depleted rats. However, when taurocholate was infused together with mevalonolactone, cholesterol 7 alpha-hydroxylase activity and catalytic efficiency were markedly depressed while enzyme mass did not change as compared with bile acid-depleted rats. These results show that (a) hepatic bile acid depletion increases bile acid synthesis mainly by activating cholesterol 7 alpha-hydroxylase with only a small rise in enzyme mass, (b) replacement with taurocholate for 24 h decreases both cholesterol 7 alpha-hydroxylase activity and mass proportionally, (c) when cholesterol is available (mevalonolactone supplementation), the infusion of taurocholate results in the formation of a catalytically less active cholesterol 7 alpha-hydroxylase, and (d) tauroursocholate, the 7 beta-hydroxy epimer of taurocholate, does not inhibit cholesterol 7 alpha-hydroxylase. Thus, bile acid synthesis is modulated by the catalytic efficiency and mass of cholesterol 7 alpha-hydroxylase. The enterohepatic flux of 7 alpha-hydroxylated bile acids and the formation of hepatic cholesterol apparently control cholesterol 7 alpha-hydroxylase by different mechanisms.
我们测定了经十二指肠输注牛磺胆酸盐及其7β-羟基差向异构体牛磺熊去氧胆酸盐的胆瘘大鼠的肝脏胆固醇7α-羟化酶活性、含量及催化效率(活性/单位含量),这些大鼠分别给予或未给予甲羟戊酸内酯以提供新合成的胆固醇。酶活性通过同位素掺入法测定,酶含量通过使用兔抗大鼠肝脏胆固醇7α-羟化酶抗血清对免疫印迹进行光密度扫描来测定。肠肝循环中断48小时后,胆固醇7α-羟化酶活性增加6倍,酶含量增加34%,催化效率增加5倍。当以等同于肝脏胆汁酸通量(27μmol/100g大鼠/小时)的速率向胆汁酸缺乏的动物输注牛磺胆酸盐时,胆固醇7α-羟化酶活性和酶含量分别下降60%和61%。牛磺熊去氧胆酸盐并未显著降低胆固醇7α-羟化酶活性、含量及催化效率。给予可转化为胆固醇的甲羟戊酸内酯,可适度增加胆汁酸缺乏大鼠的胆固醇7α-羟化酶活性和酶含量。然而,当牛磺胆酸盐与甲羟戊酸内酯一起输注时,与胆汁酸缺乏的大鼠相比,胆固醇7α-羟化酶活性和催化效率显著降低,而酶含量未改变。这些结果表明:(a)肝脏胆汁酸缺乏主要通过激活胆固醇7α-羟化酶增加胆汁酸合成,酶含量仅小幅增加;(b)用牛磺胆酸盐替代24小时可使胆固醇7α-羟化酶活性和含量成比例降低;(c)当有胆固醇可用(补充甲羟戊酸内酯)时,输注牛磺胆酸盐会导致形成催化活性较低的胆固醇7α-羟化酶;(d)牛磺胆酸盐的7β-羟基差向异构体牛磺熊去氧胆酸盐不抑制胆固醇7α-羟化酶。因此,胆汁酸合成受胆固醇7α-羟化酶的催化效率和含量调节。7α-羟化胆汁酸的肠肝循环通量和肝脏胆固醇的形成显然通过不同机制控制胆固醇7α-羟化酶。